Noninvasive routes of proteins and peptides drug delivery

被引:92
作者
Jitendra [1 ]
Sharma, P. K. [1 ]
Bansal, Sumedha [1 ]
Banik, Arunabha [1 ]
机构
[1] Meerut Inst Engn & Technol, Dept Pharmaceut Technol, Meerut 250005, Uttar Pradesh, India
关键词
Enzymes; insulin; noninvasive route; nanoparticles; protein and peptide; ORAL DELIVERY; INTESTINAL-ABSORPTION; SYSTEMIC DELIVERY; NASAL ABSORPTION; INSULIN DELIVERY; VAGINAL BROMOCRIPTINE; POSTERIOR SEGMENT; MOLECULAR-WEIGHT; FORMULATION; ENHANCERS;
D O I
10.4103/0250-474X.95608
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent advances in the field of pharmaceutical biotechnology have led to the formulation of many protein and peptide-based drugs for therapeutic and clinical application. The route of administration has a significant impact on the therapeutic outcome of a drug. The needle and syringe is a well established choice of protein and peptide delivery which has some drawback related to patient and to formulation such as pain, cost, sterility etc. Thus, the noninvasive routes which were of minor importance as parts of drug delivery in the past have assumed added importance in protein and peptide drug delivery and these include nasal, ophthalmic, buccal, vaginal, transdermal and pulmonary routes. The pharmaceutical scientists have some approaches to develop the formulations for protein and peptide delivery by noninvasive routes. But, due to the physiochemical instability and enzymatic barrier of proteins and peptides there are several hurdle to develop suitable formulation. So there is need of penetration enhancers, enzyme inhibitors and suitable vehicles for noninvasive delivery to increase the bioavailability. In this review, the aim is to focus on the approaches to formulation of protein and peptide based drug administration by noninvasive route.
引用
收藏
页码:367 / 375
页数:9
相关论文
共 103 条
[1]   Six hourly vaginal misoprostol versus intracervical dinoprostone for cervical ripening and labor induction [J].
Agarwal, N ;
Gupta, A ;
Kriplani, A ;
Bhatla, N ;
Parul .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2003, 29 (03) :147-151
[2]  
Agu RU, 2001, RESP RES, V2, P198
[3]   Study of the vaginal tolerance to acidform, an acid-buffering, bioadhesive gel [J].
Amaral, E ;
Faúndes, A ;
Zaneveld, L ;
Waller, D ;
Garg, S .
CONTRACEPTION, 1999, 60 (06) :361-366
[4]   NASAL ABSORPTION OF NAFARELIN ACETATE, THE DECAPEPTIDE [D-NAL(2)6]LHRH, IN RHESUS-MONKEYS .1. [J].
ANIK, ST ;
MCRAE, G ;
NERENBERG, C ;
WORDEN, A ;
FOREMAN, J ;
HWANG, JY ;
KUSHINSKY, S ;
JONES, RE ;
VICKERY, B .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (05) :684-685
[5]   Region-dependent role of the mucous/glycocalyx layers in insulin permeation across rat small intestinal membrane [J].
Aoki, Y ;
Morishita, M ;
Asai, K ;
Akikusa, B ;
Hosoda, S ;
Takayama, K .
PHARMACEUTICAL RESEARCH, 2005, 22 (11) :1854-1862
[6]   PHARMACOLOGICAL STUDIES OF FUT-175, NAFAMSTAT MESILATE .1. INHIBITION OF PROTEASE ACTIVITY IN INVITRO AND INVIVO EXPERIMENTS [J].
AOYAMA, T ;
INO, Y ;
OZEKI, M ;
ODA, M ;
SATO, T ;
KOSHIYAMA, Y ;
SUZUKI, S ;
FUJITA, M .
JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 35 (03) :203-227
[7]   HYDROGEL-BASED IONTOTHERAPEUTIC DELIVERY DEVICES FOR TRANSDERMAL DELIVERY OF PEPTIDE PROTEIN DRUGS [J].
BANGA, AK ;
CHIEN, YW .
PHARMACEUTICAL RESEARCH, 1993, 10 (05) :697-702
[8]   CHARACTERIZATION OF IN-VITRO TRANSDERMAL IONTOPHORETIC DELIVERY OF INSULIN [J].
BANGA, AK ;
CHIEN, YW .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1993, 19 (16) :2069-2087
[9]   Structure-function engineering of interferon-β-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation [J].
Basu, Amartya ;
Yang, Karen ;
Wang, Maoliang ;
Liu, Sam ;
Chintala, Ramesh ;
Palm, Thomas ;
Zhao, Hong ;
Peng, Ping ;
Wu, Dechun ;
Zhang, Zhenfan ;
Hua, Jack ;
Hsieh, Ming-Ching ;
Zhou, John ;
Petti, Gerald ;
Li, Xiguang ;
Janjua, Ahsen ;
Mendez, Magda ;
Liu, Jun ;
Longley, Clifford ;
Zhang, Zhihua ;
Mehlig, Mary ;
Borowski, Virna ;
Viswanathan, Manickam ;
Filpula, David .
BIOCONJUGATE CHEMISTRY, 2006, 17 (03) :618-630
[10]   Drug delivery to target the posterior segment of the eye [J].
Behar-Cohen, F .
M S-MEDECINE SCIENCES, 2004, 20 (6-7) :701-706